A phase 1 study of OSI-930 in combination with erlotinib in patients with advanced solid tumours
Year: 2012
Type: article
Study design: Clinical Trial
Source: European Journal of Cancer
Authors: I.R. Macpherson, S. Poondru, G.R. Simon, R. Gedrich, K. Brock, C.A. Hopkins, K. Stewart, A. Stephens, T.R.J. Evans
Language: English
Subfield: Molecular Biology
Domain: Life Sciences
Open Access status: closed
Funder: Cancer Research UK
Award: G6591838237
OpenAlex ID: W2039952746